Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered app aims to simplify insulin dosing for diabetes patients

NCT ID NCT07304778

First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 23 times

Summary

This study tests a mobile app called glUCModel that uses artificial intelligence to help people with type 1 diabetes decide how much insulin to take and predict their blood sugar levels. About 34 adults aged 18 to 65 will use the app along with their usual insulin injections and continuous glucose monitors. The goal is to see if the app helps keep blood sugar in a healthy range more often and reduces dangerous highs and lows.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES (INSULIN-REQUIRING, TYPE 1 OR TYPE 2) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Universitario de Toledo

    RECRUITING

    Toledo, Toledo, 45007, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Universidad Complutense de Madrid

    NOT_YET_RECRUITING

    Madrid, Madrid, 280240, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.